For questions or suggestions e-mail us at: ioerger@cs.tamu.edu
MNIQFGGRKKFRAQQVRGLTRTVAVVVAVLLVSAGLVRAPSARADGLLDFTGTTVSGAPFNGASLKGKPV VLWFWAAYCPFCNGEGPHVSAVSAANPRVTFVGISGRGSVGEMEAFISRYNLHFTNLNDADGSLWRQFGV PWQPAYLFINSNGTSDFVNNPTSSMSEQELSDRVKALT
Operon Prediction Model: Genebank
Paralogs
| species | id | gene | e-value | identity (len) | annotation |
| M. abscessus ATCC 19977 | MAB_3243 | - | - | 100% (178) | soluble secreted antigen MPT53 precursor |
| M. abscessus ATCC 19977 | MAB_4276c | - | 1e-26 | 42.40% (125) | lipoprotein DsbF |
Closest Orthologs (e-value cutoff: 1e-4)
| species | id | gene | e-value | identity (len) | annotation |
| M. bovis AF2122 / 97 | Mb2903c | mpb53 | 1e-54 | 62.42% (157) | soluble secreted antigen mpb53 |
| M. gilvum PYR-GCK | - | - | - | - | - |
| M. tuberculosis H37Rv | Rv2878c | mpt53 | 1e-54 | 62.42% (157) | soluble secreted antigen MPT53 precursor |
| M. leprae Br4923 | - | - | - | - | - |
| M. marinum M | MMAR_1831 | mpt53 | 3e-56 | 58.90% (163) | soluble secreted antigen Mpt53 precursor |
| M. avium 104 | MAV_3729 | - | 9e-52 | 61.29% (155) | 15 kDa antigen |
| M. smegmatis MC2 155 | MSMEG_3543 | - | 2e-57 | 61.25% (160) | soluble secreted antigen MPT53 |
| M. thermoresistible (build 8) | TH_2073 | mpt53 | 6e-54 | 56.44% (163) | SOLUBLE SECRETED ANTIGEN MPT53 PRECURSOR |
| M. ulcerans Agy99 | MUL_2079 | mpt53 | 2e-55 | 61.44% (153) | soluble secreted antigen Mpt53 precursor |
| M. vanbaalenii PYR-1 | - | - | - | - | - |
CLUSTAL 2.0.9 multiple sequence alignment
MMAR_1831|M.marinum_M --MTV---RPTPRNRSFAAV-LMASMVALVLTLG-LIAAPRARAADDRLD
MUL_2079|M.ulcerans_Agy99 ----------------------MASMVALVLTLG-VIAAPRARAADDRLD
MAV_3729|M.avium_104 ---------------------MAATAFAVALLLG-LGDAPRAAATDDRLQ
Mb2903c|M.bovis_AF2122/97 --MSL---RLVSPIKAFADG-IVAVAIAVVLMFG-LANTPRAVAADERLQ
Rv2878c|M.tuberculosis_H37Rv --MSL---RLVSPIKAFADG-IVAVAIAVVLMFG-LANTPRAVAADERLQ
MSMEG_3543|M.smegmatis_MC2_155 --MKMGFLRTGATARPGVLGTLSAVVATVVLATA-LVLAP-SAVADDRLQ
TH_2073|M.thermoresistible__bu --MKI---RISGTIRFLLLG---AVAA--ALTIA-LAGAP-TAVADDRLQ
MAB_3243|M.abscessus_ATCC_1997 MNIQFGGRKKFRAQQVRGLTRTVAVVVAVLLVSAGLVRAP-SARADGLLD
* * . : :* : :* *:
MMAR_1831|M.marinum_M FTATTLGGAPFNGASLQGKPAVLWFWTPWCPFCNAEGPAASQVAAANPGV
MUL_2079|M.ulcerans_Agy99 FTATTLGGAPFNGASLQGKPAVLWFWTPWCPFCNAEGPAASQVAAANPGV
MAV_3729|M.avium_104 FTATTLSGAPFNGASLQGKPAVLWFWTPWCPYCNAEAPGVSRVAAANPGV
Mb2903c|M.bovis_AF2122/97 FTATTLSGAPFDGASLQGKPAVLWFWTPWCPFCNAEAPSLSQVAAANPAV
Rv2878c|M.tuberculosis_H37Rv FTATTLSGAPFDGASLQGKPAVLWFWTPWCPFCNAEAPSLSQVAAANPAV
MSMEG_3543|M.smegmatis_MC2_155 FTGTTLSGASFDGSSLAGKPAVLWFWTPWCPFCNAEAPSVGQVAAANPEV
TH_2073|M.thermoresistible__bu FTGTTLSGTPFDGASLAGRPAVLWFWTPWCPFCNAEAPNVSRVAAANPDV
MAB_3243|M.abscessus_ATCC_1997 FTGTTVSGAPFNGASLKGKPVVLWFWAAYCPFCNGEGPHVSAVSAANPRV
**.**:.*:.*:*:** *:*.*****:.:**:**.*.* . *:**** *
MMAR_1831|M.marinum_M TFVGIAAHSDVGAMQGFVSKYGLNFTNINDADGAIWARYNVPWQPAWVFY
MUL_2079|M.ulcerans_Agy99 TFVGIAAHSDVGAMQGFVSKYGLNFTNINDADGAIWARYNVPWQPAWVFY
MAV_3729|M.avium_104 TFVGVAAHSDVGAMANFVSKYNLNFTTLNDADGAIWARYGVPWQPAYVFY
Mb2903c|M.bovis_AF2122/97 TFVGIATRADVGAMQSFVSKYNLNFTNLNDADGVIWARYNVPWQPAFVFY
Rv2878c|M.tuberculosis_H37Rv TFVGIATRADVGAMQSFVSKYNLNFTNLNDADGVIWARYNVPWQPAFVFY
MSMEG_3543|M.smegmatis_MC2_155 TFVGVAARSDVAAMQGFVDKYNLNFTNLNDADGSIWARYNVPWQPAYVFY
TH_2073|M.thermoresistible__bu TFVGVAARADVAAMQDFVNTYNLDFTNLNDADGSIWARYNVPWQPAYVFY
MAB_3243|M.abscessus_ATCC_1997 TFVGISGRGSVGEMEAFISRYNLHFTNLNDADGSLWRQFGVPWQPAYLFI
****:: :..*. * *:. *.*.**.:***** :* ::.******::*
MMAR_1831|M.marinum_M RADGSSTFVNNPTSAMSQQELADRVAALTS
MUL_2079|M.ulcerans_Agy99 RVDGSSTFVNNPTSAMSQQELADRVAALTS
MAV_3729|M.avium_104 RADGSSTFVNNPTSAMPQDELAARVAALR-
Mb2903c|M.bovis_AF2122/97 RADGTSTFVNNPTAAMSQDELSGRVAALTS
Rv2878c|M.tuberculosis_H37Rv RADGTSTFVNNPTAAMSQDELSGRVAALTS
MSMEG_3543|M.smegmatis_MC2_155 RADGSSTFVNNPTSAMSKQELSDRVAALNS
TH_2073|M.thermoresistible__bu RADGSSSFVNNPTAAMSEAELADRVAALKN
MAB_3243|M.abscessus_ATCC_1997 NSNGTSDFVNNPTSSMSEQELSDRVKALT-
. :*:* ******::*.: **: ** **